Mansour bin Mohammed opens the Medlab Middle East 2024 exhibition and conference

His Highness Sheikh Mansour bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Board of Directors of Dubai Health, opened this morning (Monday) the activities of the twenty-third edition of the Medlab Middle East Exhibition and Conference 2024, the largest exhibition and conference for medical laboratories in the Middle East and North Africa region, which is held at the Dubai Trade Center. Global event with the participation of more than 900 exhibiting companies from more than 40 countries.

During the tour, in which he was accompanied by His Excellency Hilal Saeed Al Marri, Director General of the Dubai World Trade Center Authority, His Highness was briefed on the innovative technologies that the exhibition offers this year, and the opportunities it provides for learning and exchanging expertise and successful experiences in the field of medical laboratories, and the most important topics that will be discussed at the conference. Accompanied by more than 130 speakers.

His Highness Sheikh Mansour bin Mohammed bin Rashid Al Maktoum listened to an explanation about the exhibition’s international pavilions and platforms, through which major international companies and entities specialized in this field participate, and through which the latest laboratory innovations are displayed across eight categories of products, which include emergency medicine. , imaging and diagnostics, healthcare and public services, information technology, laboratories, medical equipment and devices, pharmacy and nutrition, and consumables and consumer goods.

During the tour, His Highness was keen to visit a number of participating international pavilions, which included the pavilions of the United States of America, Germany and Spain, where His Highness was briefed on the latest technologies, solutions, products and medical laboratories displayed by the exhibitors from those countries.

During the tour, His Highness visited the pavilion of the “Pure Lab” company, which operates and manages the largest network of accredited medical laboratories in the region, which currently totals more than 160 medical laboratories throughout the country. His Highness’s tour also included a visit to the “Riviti” company platform, where His Highness listened to an explanation about the company’s leading solutions, technologies and services in the field of health care, starting with disease detection, then diagnosis and treatment, including a special focus on multidisciplinary omics technologies, identifying vital signs, imaging, prediction, screening, detection and diagnosis. and informatics.

His Highness visited the pavilion of the American company BECKMAN COULTER, where His Highness was briefed on the company's work, which includes developing, manufacturing and marketing products for biomedical tests. His Highness also visited the pavilion of Abbott Laboratories, an international American company specialized in the field of medical laboratories and health care, whose products are spread in more than 130 countries.

His Highness also visited the pavilion of BIOMERIEUX, a multinational biotechnology company, where His Highness listened to an explanation about the company’s global activity, which provides diagnostic solutions that determine the source of disease and pollution to improve patient health and ensure consumer safety through its branches in 44 countries.

His Highness Sheikh Mansour bin Mohammed bin Rashid Al Maktoum was keen to visit the Papyrus pavilion, which is one of the leading companies in the field of supplying medical equipment in the UAE, and helps provide innovative diagnostic solutions in three main areas: molecular diagnostics, personalized medicine, and immunodiagnostics. . His Highness's tour included a visit to Sysmex, a company specialized in healthcare technology and a global leader in the field of blood disease diagnostics and services, which is considered among the best diagnostic companies in the world in eight fields: hematology, life sciences, urinalysis, primary care, blood coagulation and chemistry. Immunology, basic health care, flow cytometry.

His Highness also inspected the platform of the Chinese company “Snibe Diagnostics”, which is a leading provider of laboratory solutions and technologies for disease prevention, diagnosis, treatment monitoring, diagnosis monitoring, and assessment of health status and genetic diseases.

Expansions

In confirmation of Medlab Middle East's commitment to innovation, a new area and conference have been added, as the Next Generation Medicine area was added to the exhibition this year, which is held in partnership with ExpressMed Diagnostics and Research Company, and occupies an exhibition area of ​​1,500 square meters and includes more than 100 exhibitors, where Several topics will be discussed during the Next Generation Medicine Conference, including: genomic medicine, precision medicine, longevity, and anti-aging.

Tom Coleman, Exhibition Director for Medlab – Informa Markets Healthcare EMEA, said: “Last year was a record year for Medlab Middle East, with deals worth AED 1.9 billion being achieved, and in light of this achievement we expect a 20% increase in sales. Numbers of visitors this year, and we also have some new events that have been added to this year’s edition, which will in turn enhance the overall impact, both for exhibitors and attendees.”

The Medlab Middle East 2024 conference will witness a range of innovations and solutions to develop laboratory skills and improve laboratory functions through 12 conferences, as the event is the largest multi-track medical laboratory conference accredited by continuing medical education in the world and includes more than 130 local and international speakers.

This year's conference program includes: next generation medicine, laboratory management, laboratory quality management, clinical chemistry, immunology, hematology, clinical microbiology, clinical genomic interpretation, transfusion medicine, histology, the future of the laboratory and sustainability in the laboratory.

The first day of the Medlab Middle East exhibition included Frost & Sullivan hosting a discussion session on “Strategic Investments and Growth Opportunities: Reshaping the Future of the Laboratory and Diagnostics Industry in the Middle East.” A panel of elite healthcare leaders at Think Tank also discussed key industry topics including the key drivers and challenges facing the laboratory and diagnostics industry in the Middle East and the technologies expected to drive growth in the industry in the coming years in the presence of representatives from Abbott, Randox, Thermo Fisher, and Cleveland Clinic. Dr Bernie Croal, President-Elect of the Royal College of Pathologists in the UK presented “Strategies to Ensure Laboratory Tests Are Focused and Safe” at the Laboratory Management Conference, while Dr Lubna Al Zadjali, Consultant Hematologist from Sultan Qaboos University Comprehensive Cancer Center Muscat spoke at the Hematology Conference. About laboratory information systems for hematology